Mustang Bio (MBIO)

• Market cap: $3.99M
• 1 day: 2.89%
• 5 days: 7.39%
• 1 month: -4.55%
• 3 months: -24.82%
• 6 months: -34.92%
• Year to date: -50.82%
• 1 year: -67.52%
• 5 years: -99.97%
• 10 years: -99.99%
• Sector: Healthcare
• Industry: Biotechnology

About: Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Employees: 4